Saturday, December 22, 2012

Daily ETF Roundup: XLK Leads The Rebound, VXX Sinks Lower

Equity markets staged a ferocious rebound today following Monday’s dismal sell-off. Investors brushed aside worse-than-expected economic data on the home front, instead focusing on upbeat commentary from the�International�Monetary Fund (IMF) as well as a successful Spanish bond auction overseas. On Wall Street, the Nasdaq charged ahead, clinching gains of 1.82% on the day, while the Dow Jones Industrial Average just barely lagged behind, gaining 1.50% as the trading session drew to a close [see Free Report: Everything You Need To Know About Commodity ETFs].

Housing market and manufacturing data releases both came in worse-than-expected; housing starts in March came in at 654,000 versus the expected 703,000, while industrial production�figures came in flat, versus�expectations�of 0.3% growth. Nonetheless, bullish forces prevailed across equity markets around the world after the IMF raised its global economic growth�forecasts�for 2012 and 2013, citing improving financial conditions in the U.S. as well as across emerging markets [see 5 ETFs For The Earnings Bull].

The State Street Technology Select Sector SPDR (XLK) was one of the strongest performers, gaining 2.18% on the day. Gains in the technology sector were largely fueled by Apple’s impressive rebound on Tuesday; shares of the consumer electronics giant rallied close to $30, gaining just over 5% on the day. Heavy trading volumes in XLK came in just before the closing bell, perhaps suggesting that bullish momentum has returned for good [see High Tech ETFdb Portfolio].

The Barclays iPath S&P 500 VIX Short-Term Futures ETN (VXX) was one of the worst performers, shedding a dismal 5.27% on the day. Uncertainty seemingly evaporated from the market as investors digested an optimistic outlook from the IMF along with easing concerns surrounding the latest Spanish debt auction. The VIX Index fell below the 20 mark right from the opening bell, managing to settle just under the 19 mark as the closing bell rang [see also Euro Drama Is Back: Trade The Range In FXE].

[Download�7 Cheap & Simple All-ETF Portfolios�with a free ETFdb membership; sign up for the�ETFdb newsletter�to get updates on all new ETF launches]

Transocean Reports Q2 Earnings On August 2

Transocean Ltd. (RIG) is scheduled to report its Q2 2012 results on August 2, 2012, before the market opens. The street expects EPS and revenue of $0.44 and $2.49B, respectively.

In this article I will recap the historical results of the company, its latest EPS estimates vs. surprises, the latest news from RIG and the news from its closest competitors.

Recent EPS Actuals vs. Estimates

The company has met or beaten analysts' estimates in the last two quarters. In the last quarter it reported $0.64 EPS, beating analyst estimates of $0.33.

The consensus EPS estimate is $0.44 based on 31 analysts' estimates, down from $0.64 a year ago. Revenue estimates are $2.49B, up from $2.33B a year ago. The median target price by analysts for the stock is $65.00.

Average recommendation: Overweight

Source: Marketwatch

Analyst Upgrades and Downgrades

  • On April 11, 2012, FBR Capital reiterated Outperform rating for the company.
  • On March 15, 2012, Global Hunter Securities upgraded the company from Neutral to Buy.
  • On February 28, 2012, RBC Capital Mkts reiterated Outperform rating for the company.
  • On February 28, 2012, FBR Capital reiterated Outperform rating for the company.
  • On February 14, 2012, HSBC Securities reiterated Overweight rating for the company.

Latest News

  • On July 18, 2012, Transocean Ltd. issued a comprehensive Fleet Status Report which provides current status and contract information for the company's entire fleet of offshore drilling rigs. Since the June update, backlog associated with new contracts or extensions is approximately $1.5 billion and 2012 estimated out of service time increased by a net 16 days.
  • On June 14, 2012, Transocean Ltd. issued a monthly fleet update summary which includes new contracts, significant changes to existing contracts, and changes in estimated planned out of service time of 15 or more days since the May 17, 2012 update. Since the May update, backlog associated with new contracts or extensions is approximately $2.5 billion and planned 2012 out of service time decreased by a net 19 days.
  • On May 17, 2012, Transocean Ltd. issued a monthly fleet update summary which includes newly signed contracts, significant changes to existing contracts, and changes in estimated planned out of service time of 15 days or longer for all rig classifications since the previously issued comprehensive fleet status report. Backlog associated with new contracts or extensions since the April 18, 2012 fleet status report is approximately $726 million. Planned 2012 out of service time increased by a net 471 days, which includes 320 days (68 percent) associated with rigs preparing for new or potential contracts and 105 days (22 percent) related to recertification of well control equipment on two additional rigs.
  • On May 3, 2012, Reuters reported that BP plc won preliminary court approval of an estimated $7.8 billion settlement to resolve more than 100,000 claims by individuals and businesses stemming from the 2010 Gulf of Mexico oil spill.

Competitors

Atwood Oceanics (ATW), Diamond Offshore Drilling (DO), Ensco (ESV), and Noble Corp. (NE) are considered major competitors for Transocean and the table below provides the key metrics for these companies and the industry.

The chart below compares the stock price changes as a percentage for the selected companies and S&P 500 index for the last one year period.

RIG data by YCharts

Competitors' Latest Development

  • On July 19, 2012, Diamond Offshore Drilling Inc announced that the Company has declared a special quarterly cash dividend of $0.75 per share of common stock and a regular quarterly cash dividend of $0.125 per share of common stock.
  • On July 12, 2012, Noble Corporation announced that the Company has entered into a three-year term drilling contract with Anadarko Petroleum Corporation for the Noble Bob Douglas, one of Noble's new ultra-deepwater drillships currently under construction at the Hyundai Heavy Industries Co. Ltd. (HHI) shipyard in Ulsan, South Korea.
  • On July 10, 2012, Atwood Oceanics Inc announced that one of its subsidiaries has been awarded a twelve-month contract extension with an affiliate of Coastal Energy Company for the jackup rig Vicksburg.
  • On July 9, 2012, Atwood Oceanics, Inc., announced that one of its subsidiaries has been awarded a drilling services contract by Glencore Exploration Cameroon Ltd for the jack-up rig Atwood Aurora.
  • On May 3, 2012, Ensco plc announced that for second quarter of 2012, it expects revenues to increase approximately 6% from first quarter of 2012. The Company reported revenue of $1.03 billion in first quarter of 2012.
  • On April 27, 2012, Atwood Oceanics Inc announced that one of its subsidiaries has been awarded a drilling services contract by a subsidiary of Noble Energy Inc. for the Atwood Hunter for three firm wells with a minimum total duration of 150 days plus one option well.
  • On April 23, 2012, Atwood Oceanics Inc announced that one of its subsidiaries has been awarded a three year contract extension by Chevron Australia Pty Ltd (Chevron), for the semisubmersible Atwood Osprey.
  • On April 19, 2012, Diamond Offshore Drilling Inc announced that the Company has declared a special quarterly cash dividend of $0.75 per share of common stock and a regular quarterly cash dividend of $0.125 per share of common stock.
  • On March 28, 2012, Hercules Offshore, Inc. announced that it has closed the previously announced acquisition of the offshore drilling rig Ocean Columbia from a subsidiary of Diamond Offshore Drilling, Inc. for $40 million in cash.
  • On March 22, 2012, Atwood Oceanics Inc announced that one of its subsidiaries has been awarded a contract by Salamander Energy (Bualuang) Limited, for the newbuild jackup Atwood Mako.
  • On March 21, 2012, Diamond Offshore Drilling Inc. announced the execution of a definitive agreement to sell its subsidiary's jack-up drilling rig, Ocean Columbia, to a subsidiary of Hercules Offshore, Inc., for a sale price of $40 million in cash.
  • On February 29, 2012, Ensco plc announced that its Board of Directors has declared a regular quarterly cash dividend of $0.375 per Class A ordinary share payable on 23 March 2012 to holders of Ensco's American depositary shares (ADS) as of the March 12, 2012, record date.
  • On February 23, 2012, Ensco plc announced that for first quarter of 2012, it expects revenue to increase approximately 8% from the fourth quarter. The Company reported revenue of $994.90 million in fourth quarter of 2011.
  • On February 7, 2012, Atwood Oceanics Inc announced that one of its subsidiaries has been awarded a drilling services contract by Shemen Oil and Gas Resources Ltd., an Israel-based oil and gas company, for the Atwood Beacon.
  • On February 2, 2012, Diamond Offshore Drilling Inc. announced that the Company has declared a special quarterly cash dividend of $0.75 per share of common stock and a regular quarterly cash dividend of $0.125 per share of common stock.

Technical Overview


The stock has a market capitalization of $15.84B and is currently trading at $45.19 with a 52 week range of $38.21 - $62.87. The stock's year-to-date performance has been 19.61%. It is currently trading above 50 SMA, but below 20 and 200 SMA.

Sources: Yahoo Finance, Google Finance, Marketwatch, Finviz, Reuters.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Why Financial SPDR ETF Is a Buy – Bank Earnings Better Than You Think

Although mega banks JPMorgan (JPM), Citigroup (C), and Bank of America (BAC) have all reported better than expected earnings results — only to be knocked to the ground by unimpressed investors. The problem, is that the earnings beats are being driven by reduction in loan loss provisions, which are like accounting piggybanks that are used to protect against defaults.

An optimist would say that these reductions are a result of a strengthening economy and improvements in the number of people who can pay their loans on time. You can see this in the way that loan charge-offs are declining: Quarter-over-quarter, they fell $1.2 billion at Bank of America, $422 million at Citigroup, and $2.2 billion at JPMorgan.

And the trends are expected to continue as job creation ramps up. On Thursday, initial weekly jobless claims fell to 429k from 454k previously — falling out of a range between roughly 450k and 500k that the metric has been stuck in since October.

But the skeptics are having none of it. Bank stocks have tumbled over the last two days on concerns bank executives are using creative tactics to dress up their earnings — prematurely tapping into their credit reserves. There are also concerns over a decline in revenues: The top line dropped 7.6% year-over-year at JPMorgan, 33.3% at Citigroup, and 11% at Bank of America. And of course, there are worries over the hit to profitability related to the passage of financial regulatory reform legislation in Washington.

As a result, you can see in the chart above how bank stocks have failed at triple top resistance that has contained the Financial SPDR (XLF) since May. And this underperformance by the financials is what’s dragging down the broad market.�

Are the concerns valid? Or is this another example of excessive pessimism?

I think there is some reason for optimism. The decline in loan losses is an unmitigated positive. And the decline in revenue might be due to some shrewd prepositioning by executives to protect themselves against an increase in interest rates. Analysts at FBR Capital note that JPMorgan shortened the average maturity of its securities portfolio. Translation: The bank is selling long-term Treasury bonds and buying more short-term Treasury bills instead.

That cuts the losses the bank will take on its portfolio should the economy continue to improve and the Fed starts raising rates. This is exactly the right step to take and will help boost profitability into the future. This is because the value of long-term bonds drop more severely than short-term bonds as rates rise.

And as for the hit from regulatory reform, I think it’s already priced in. A recent Citigroup analysis of the legislation found that under very conservative assumptions, Bank of America would see earnings per share fall 16% while JPMorgan would suffer an 18% impact. From the April high, Bank of America has dropped 28% while JPMorgan is down nearly 19%.

Once the XLF moves through $15, I’m a buyer.

The One Top ETF to Own Now – Louis Navellier’s new profit guide reveals the hottest ETF to buy now, plus details his breakthrough new strategy designed to help you lock in short-term gains from ETFs in sectors just heating up, and then when those sectors are on fire, grab money-doubling profits from the fastest-moving individual stocks — download your FREE copy of this report here.

Merk Notes Inflation Risk

Currency experts at Merk Mutual Funds have an interesting point of view on the inflation-deflation debate. In an outlook article on their Web site, "Inflation: The Runaway Train,"analyst Kieran Osborne notes that because there are currently, "$1.1 trillion of bank reserves just sitting on the sidelines waiting to be deployed," due to banks' unwillingness to lend right now, and that once they become less afraid to lend, this liquidity would pour into the U.S. economy and create an inflationary environment.

The environment would be caused by an increase in the "velocity of money" in the economy, "which slowed down considerably throughout the crisis (a key reason why all the additional money printing has not yet been inflationary)," according to the article.

Comments? Please send them to kmcbride@wealthmanagerweb.com. Kate McBride is editor in chief of Wealth Manager and a member of The Committee for the Fiduciary Standard.

Something Worth Watching at Merge Healthcare

There's no foolproof way to know the future for Merge Healthcare (Nasdaq: MRGE  ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.

A cloudy crystal ball
In this series, we use accounts receivable and days sales outstanding to judge a company's current health and future prospects. It's an important step in separating the pretenders from the market's best stocks. Alone, AR -- the amount of money owed the company -- and DSO -- the number of days' worth of sales owed to the company -- don't tell you much. However, by considering the trends in AR and DSO, you can sometimes get a window onto the future.

Sometimes, problems with AR or DSO simply indicate a change in the business (like an acquisition), or lax collections. However, AR that grows more quickly than revenue, or ballooning DSO, can, at times, suggest a desperate company that's trying to boost sales by giving its customers overly generous payment terms. Alternately, it can indicate that the company sprinted to book a load of sales at the end of the quarter, like used-car dealers on the 29th of the month. (Sometimes, companies do both.)

Why might an upstanding firm like Merge Healthcare do this? For the same reason any other company might: to make the numbers. Investors don't like revenue shortfalls, and employees don't like reporting them to their superiors.

Is Merge Healthcare sending any potential warning signs? Take a look at the chart below, which plots revenue growth against AR growth, and DSO:

Source: S&P Capital IQ. Data is current as of last fully reported fiscal quarter. FQ = fiscal quarter.

The standard way to calculate DSO uses average accounts receivable. I prefer to look at end-of-quarter receivables, but I've plotted both above.

Watching the trends
When that red line (AR growth) crosses above the green line (revenue growth), I know I need to consult the filings. Similarly, a spike in the blue bars indicates a trend worth worrying about. Merge Healthcare's latest average DSO stands at 141.5 days, and the end-of-quarter figure is 140.3 days. Differences in business models can generate variations in DSO, and business needs can require occasional fluctuations, but all things being equal, I like to see this figure stay steady. So, let's get back to our original question: Based on DSO and sales, does Merge Healthcare look like it might miss its numbers in the next quarter or two?

The numbers don't paint a clear picture. For the last fully reported fiscal quarter, Merge Healthcare's year-over-year revenue grew 0.5%, and its AR grew 10.5%. That looks OK. End-of-quarter DSO increased 9.9% over the prior-year quarter. It was up 3.5% versus the prior quarter. Still, I'm no fortuneteller, and these are just numbers. Investors putting their money on the line always need to dig into the filings for the root causes and draw their own conclusions.

Is Merge Healthcare the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

  • Add Merge Healthcare to My Watchlist.

Finding Value in Vale

Vale (NYSE:VALE) engages in the exploration, production and sale of basic metals in Brazil and internationally. It’s also involved in fertilizers, logistics and steel businesses. In addition, Vale generates energy through hydroelectric power plants.

While the U.S. equity market has seen a rough patch lately, foreign markets have been beaten up to a much greater degree. One of the worst performers has been Brazil, which is down nearly 10% YTD. Brazil is now trading at a big discount to U.S. stocks on a valuation basis, while still showing much better growth prospects.

Ally Financial’s ResCap: A Smart Bankruptcy

Of the Brazilian stocks, Vale has been probably the most unduly punished. The stock is now trading at a price-earnings ratio of less than� 6 and sports a very healthy 5.6% dividend yield. Compared to the yield on 30-year U.S. Treasuries of under 3%, Vale certainly looks attractive.

With VALE currently priced under 20 for the first time since 2009, the stock is now trading at a trough valuation. Combined with the high yield, I look for VALE to head back to 22 by September expiration.

Based on Vale’s closing market price of $19.02 for May 15, and using a target price of $22 and a target date of Sept. 21, option strategies to consider include buying a September call spread, selling a September put spread, buying a September call or using another options strategy that best fits your trading style and risk-return objectives.

For the full details on this trade, visit TradingBlock.com, create a free Instant Login and try the TradeBuilder feature, where you�ll see several ways to trade this name. Best of all, you can see a potential profit-and-loss outline for each strategy.

Create your free login, and get access to the details about these VALE options trading strategies by visiting TradeBuilder here.

As of this writing, Tim Biggam does not own any shares mentioned here.

Friday, December 21, 2012

You Could Make You 3,800% Gains from This Technology Breakthrough

Insiders call it the �magic drug�… but it�s not a pill you swallow. It�s not something that your doctor will prescribe. It�s a special solution being injected right now into thousands of oil wells across America.

It frees up massive amounts of crude oil from deposits on dry land once thought to be inaccessible. While most investors don�t know anything about this extraordinary phenomenon, it�s filling the coffers of some little-known American oil companies with tons of cash.

It�s a big breakthrough for the nation�s oil industry.

As the Natural Resources Defense Council points out, it, �would give America access to large, domestic oil resources � potentially more than four times the proven U.S. reserves, or up to 10 full years of our total national consumption.� That�s a quadrupling of U.S. oil reserves.

Now here�s where the action is the hottest: The Bakken trend. This U.S. region lies in the giant Williston Basin and stretches across parts of the Dakotas, Montana, Manitoba and Saskatchewan…

In the 1990s, geochemist L.C. Price, working for the U.S. Geological Survey (USGS), compiled a stunning report on the Bakken trend. He concluded that it contained 200�500 billion barrels of oil. In 1999, he turned in his report to the USGS, but nothing happened. In 2000, Price died, but the USGS still had the report. The USGS refused to release it. Price�s story of Bakken was the province of oilmen telling stories in bars… until today.

It took the force of a North Dakota senator to press the USGS to take up where Price left off. But finally, the Bakken has the world�s attention. New work on the area confirms the essence of Price�s research, if not his 200�500 billion barrel estimate. Some 2006 estimates place 300 billion in North Dakota and Montana alone.

Also, geologist Julie LeFever, who worked with L.C. Price on his initial report, published a paper adding that additional barrels lie in various layers of the Bakken.

What does this mean for the smart oil and gas investor? Prospects of returns far better than anything you�ve ever heard of from the Canadian oil sands or Colorado�s shale.

�The Bakken formation estimate is larger than all other current USGS oil assessments of the lower 48 states,� the report says �and is the largest �continuous� oil accumulation ever assessed by the USGS.�

Who knows exactly how much oil lies beneath the Bakken? On April 10, 2008, the USGS issued a shot heard round the Bakken. Its newest estimation reveals a 25-fold increase in the amount of oil that can be recovered from the Bakken formation. North Dakota and Montana�s Bakken alone have an estimated 3�4.3 billion barrels of oil that could be recoverable with today�s �magic drug� technology. The Bakken has suddenly become one of the hottest crude oil plays in North America. Already, investors from Norway, the United Kingdom, France and Italy are in on the game. Private equity predicts Asian investors will be next…

Bakken, you see, is just that big. Predictions for peak daily production range from a healthy 300,000 barrels per day (bpd) to a whopping 700,000 bpd. That kind of production could last 10�15 years. Meanwhile, the Gulf of Mexico produces half what it did 10 years ago. The Bakken is the future of U.S. energy.

And there�s even bigger news… a new formation under the Bakken shale. Three Forks-Sanish could prove just as good as the Bakken. This is just what geologist Julie LeFever suggested back in �06. Three Forks� sand and porous rock could offer up 1.9 billion barrels of oil using current technology. At least that�s the latest number I have from North Dakota�s Industrial Commission. But Harold Hamm, CEO of Continental Resources (a key player in the Three Forks) claims there could be as much as 8 billion barrels.

Getting oil and gas out of the Bakken has never been easier. Since just 2008, Bakken�s experienced drill teams have whittled down the time it takes to drill over two miles down into the shale. What once took 45 days now takes only 19.

Right now, the Bakken has put a record number of rigs to work. Things haven�t been this busy since 1981. About 6,000 wells produce in just the North Dakota Bakken alone. The region added over 1,000 new wells since 2008, when I first started covering this resource bonanza.

Early investors in shale oil and gas have made fortunes.

Take Range Resources, for instance, a company that locked down a lot of shale acreage early in the other big shale finds � the Barnett and Marcellus. It�s up 2,294% in the last 10 years.

Specifically in the Bakken formation, my readers cashed out on shale player Kodiak Oil & Gas for 113% gains.

So there is a ton of money to be made from this new technique. And if you take advantage of this tidal wave, it could make you wealthier than you�ve ever thought possible…

IPO Market Shifts to Growth: Q1 2010 Global Review

With 100 deals and $45 billion in proceeds raised, the 1Q10 was the second best quarter for global IPO issuance since the end of 2007. More importantly, signals of increasing risk appetite suggest that the market may be at an inflection point. We believe that the composition of the IPO Market is undergoing an important shift that has implications for both future issuance and the global economic outlook. Continuing a trend from late 2009, mature companies in cyclical industries dominated early first quarter deal flow, and investor sensitivity to valuations caused performance to suffer. However, with the number of global tech deals doubling from the 4Q09 and US venture-backed companies beginning to see daylight, we could be witnessing the revival of the IPO market's traditional growth sectors.

1Q 2010 global IPO issuance soars relative to a depressed 1Q 2009
Quarterly tallies of 100 deals and $45 billion in proceeds are light years ahead of those from the turbulent 1Q09, which saw only two IPOs raise a combined $0.9 billion in proceeds. Looking back to a more normalized market for context, the 1Q10 matched the 1Q07 in deal activity (100 versus 100) and exceeded the 1Q07 in terms of total proceeds raised ($45b versus $32b). Additionally, the 1Q07 represented only 18% of full-year 2007 deals and 13% of proceeds, suggesting that the IPO calendar could get busier in the remainder of 2010.

China dominates deal flow; pulls up global performance
China led all markets in terms of deal flow for the third consecutive quarter, with 39 companies going public. However, it barely edged Japan on a total proceeds basis ($12.3 billion versus $11.4 billion), with leading Japanese insurance company Dai-ichi Life raising $11.0 billion in the largest global IPO since Visa (V). The average IPO returned 23.8% from its offer price, down slightly from 24.3% in the 4Q09. The median IPO return was 14.5%, with nearly three quarters of IPOs trading above their IPO prices. Overall, China-traded IPOs bolstered global returns with a blistering 44.8% average rise, and Shanghai accounted for 15 of the top 20 global performers. Specifically, five of the top 10 performers were China-traded tech companies; this group produced an impressive 111.8% average return. Not surprisingly, Asia Pacific was the top performing region with a 34.8% average return, while North America, Europe and Latin America lagged with 8.1%, 4.8% and 4.7% average gains, respectively. The top US performer, technology-enabled portfolio advisor Financial Engines (FNGN), was the only North American deal in the top 20, with a 40.8% return from its offer price.

An Inflection Point in the US Market?
On a year-over-year basis, the number of US deals increased sharply to 27, though proceeds were up only four-fold as a result of the $720 million Bristol Myers Squibb (BMY) carve-out of baby nutrition company Mead Johnson Nutrition (MJN) in the prior period. By comparison, the largest 1Q10 US deal was the $570 million offering of sensor and controls maker Sensata Technologies (ST), and the average deal size declined to $162 million (down 60% from the 4Q) driven by a March surge in deals from smaller cap growth IPOs.

The largest US deals come from mature industries
In a continuation of a 2009 trend, private equity firms were behind three of the five largest US deals in the 1Q10, including Sensata Technologies, life insurer Symetra Financial (SYA) and standby generator manufacturer Generac Holdings (GNRC). Overall, private equity-backed IPOs represented 37% of proceeds raised in the first quarter of 2010, up from 30% for the full year 2009. Rounding out the top five were Primerica (PRI), a carve-out of Citi's (C) life insurance business that priced on March 31, and Crude Carriers (CRU), a newly-formed shipping company.

Venture Capital Springs to Life in March
The US IPO market brought more positive signals as we moved into March. With Euro-zone debt concerns easing and the Fed renewing its commitment to record low interest rates, upward momentum in the broader market supported an increase in deal flow, particularly from the small cap tech and biotech sectors. On average, first day returns improved to 11.7% versus a -1.5% loss in January and February. Despite the shorter horizon, deals priced in March have returned 9.7%, versus 4.3% for earlier 1Q10 deals, and represent three of the quarter's top five gainers.

March also saw a welcome uptick in venture capital-backed IPOs (5), driving the highest quarterly total (9) since the end of 2007. These deals vastly outperformed their non-venture peers with a first day pop of 14.3% (versus -0.1%) and total return of 14.8% (versus 2.9%). Interestingly, this group included the largest biotech IPO since 2002 in Ironwood (IRWD), and offerings from sectors that had been dormant since 2007, including fabless chip designed MaxLinear (MXL) and telecom equipment vendor Calix (CALX). The strong performance for these three deals suggests that US IPO investors are moving further out on the risk spectrum.

Outlook
With the uptick in venture-backed activity and solidIPO performance, it is not surprising to see continued momentum in new filings from growth sectors. Growth-oriented technology and healthcare companies currently represent a quarter of prospective IPOs in the pipeline, and venture-backed companies accounted for 38% of new IPO filings in the 1Q10. While stable companies in mature industries continue to drive global issuance, performance is increasingly favoring the smaller and faster-growing companies that have historically been the engine of the IPO market. Particularly in the US, improving liquidity in the venture channel suggests that IPO investors are looking beyond the deleveraging phase of the global recovery and toward the next sources of economic growth.

Note: All global statistics include IPOs that raised over $100 million in gross proceeds. US market statistics include IPOs with a proposed market cap above $50 million and exclude closed-end funds.

Top Stocks For 12/3/2012-7

Power3 Medical Products, Inc. (OTC.BB:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer�s and Parkinson�s, to name a few.

Alzheimer’s doesn’t have any immediate cure, but remedies for indicators can be found and investigation carries on. Even though current Alzheimer treatment options cannot cease Alzheimer’s disease from progressing, they’re able to temporarily decrease the speed of the deterioration involving signs of illness in addition to advance quality of life for the people with Alzheimer’s disease as well as all their caregivers. Today, there exists a international exertion under approach to finding better ways to take care of the condition, postponement its onset, and prevent it from escalating.

World wide, breast cancer comprises 10.4% of all cancer among women, which makes it the most common type of non-skin cancer in females and also the fifth most popular grounds for cancer death.

Parkinson�s disease (PD) is part of a team of ailments known as motor system disorders, which are the result of the loss of dopamine-producing brain cells.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer�s disease, Parkinson�s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig�s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.

American Video Teleconferencing Corp. (Pink Sheets:AVOT) is pleased to announce that it is presently in final discussions to enter into a formal agreement to acquire an exclusive option on a molybdenum property in the Otter lake area in the province of Quebec, Canada.

The property has been dormant since the 1960�s when Hupon Mining and Exploration carried out surface work, stripping, trenching and a minor drill program of 445 feet contained in 11 drill holes. Some of the sample results from the trenching in 1962 showed 0.94% to 25% molybdenum averaging 5-10%. These values were obtained from assessment files in the Department of Mines in Quebec City.

This property is only one of several advanced stage properties American Video has under consideration in the province of Quebec.

Contrary to their name, rare-earth metals are abundant in the Earth’s crust, and significant reserves are concentrated in the United States, Australia, Brazil, and other countries. According to the U.S. Geological Survey, there are 13 million tons of extractable rare earths in the United States, 5.4 million in Australia, and 19 million in Russia and neighboring countries. In 2009, China had 36 million.

Rare earths�minerals, metals and their oxides�have been a looming problem for several years but became a political football recently when China reduced its export quotas for the second half.

American Video will aggressively continue to search world-wide for opportunities in Precious, Base and Rare Earths metal projects.

Hampden Bancorp, Inc. (Nasdaq:HBNK) announced that its Board of Directors authorized a fourth stock repurchase program (the �Stock Repurchase Program�) for the purchase of up to 339,170 shares, or approximately 5%, of the Company�s outstanding common stock. The Company will commence its fourth stock repurchase program immediately upon the completion of its third repurchase program, announced on June 2, 2010, which has 38,843 shares remaining. Any repurchases under the Stock Repurchase Program will be made through open market purchase transactions from time to time.

Hampden Bancorp, Inc. operates as the holding company for Hampden Bank that provides various banking and financial services to individuals and small businesses in Hampden County, Massachusetts.

Audiovox Corporation (Nasdaq:VOXX) announced results for its Fiscal 2011 third quarter ended November 30, 2010. Commenting on the Company’s performance, Pat Lavelle, President and CEO stated, “During the third quarter, our automotive business, both in the aftermarket and at the OE level, continued to offset the weakness in our consumer and accessory categories. Concerns over the state of the U.S. economy remain and while our sales in these groups are lower than last year, we gained several new retail accounts, which is encouraging for the future.

Audiovox Corporation, through its subsidiaries, operates as a distributor and value added service provider in the accessory, mobile, and consumer electronics industries.

The Knot, Inc. (Nasdaq:KNOT) announced its annual forecast for the hottest wedding trends for 2011. �Whether it�s Boardwalk Empire, food trucks or man caves, 2011 couples will want a wedding that reflects their personal passions, shows guests a really good time and, ultimately, will be an event that people will talk about for months to come,� predicts Carley Roney, cofounder and editor in chief of TheKnot.com.

The Knot, Inc. provides multiplatform media services to the wedding, newlywed, and pregnancy markets in the United States. The company provides online and offline services through various media, such as magazines, books, syndication, television, Web sites.

Kodak, trying to stay afloat, rejiggers itself

NEW YORK (CNNMoney) -- Eastman Kodak, the venerable but struggling photography company, announced Tuesday that it has streamlined its corporate structure as part of the ongoing effort to evolve from film to digital.

The move comes amid speculation that the company, which once was a component of the Dow Jones industrial average, is near a bankruptcy filing.

Kodak said the company is now structured into two divisions, the commercial segment and the consumer segment, as of Jan. 1. These segments will report to the newly created chief operating office, which is led by Philip Faraci and Laura Quatela.

The company was previously organized into three divisions, the graphic communications group, the consumer digital imaging group and the film, photofinishing and entertainment group.

Kodak: Death of an American icon?

Kodak spokesman Christopher Veronda did not answer a question from CNNMoney as to whether any employees would lose their jobs as part of the changes.

Veronda declined to comment on whether the changes are a precursor to a bankruptcy filing.

"This organizational structure change has been in development since completion of our annual internal strategic reviews," he said. "We are not commenting on market speculation and rumors."

Bankruptcy speculation has dogged the company since last year. It became stronger on Jan. 3, when the Wall Street Journal reported that a filing was imminent. Kodak's (EK, Fortune 500) stock has plunged about 20% over the last five days.

The company denied the reports, causing the stock to recover somewhat. But the stock is down by 90% over the last year.

Kodak was a relatively early pioneer in the field of digital photography, though it has been slow to leave behind its heavy reliance on outmoded film technology. 

How Ingles Markets is Bringing Bucks Home More Quickly

It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?"

When judging a company's prospects, how quickly it turns cash outflows into cash inflows can be just as important as how much profit it's booking in the accounting fantasy world we call "earnings." This is one of the first metrics I check when I'm hunting for the market's best stocks. Today, we'll see how it applies to Ingles Markets (Nasdaq: IMKT.A  ) .

Let's break this down
In this series, we measure how swiftly a company turns cash into goods or services and back into cash. We'll use a quick, relatively foolproof tool known as the cash conversion cycle, or CCC for short.

Why does the CCC matter? The less time it takes a firm to convert outgoing cash into incoming cash, the more powerful and flexible its profit engine is. The less money tied up in inventory and accounts receivable, the more available to grow the company, pay investors, or both.

To calculate the cash conversion cycle, add days inventory outstanding to days sales outstanding, then subtract days payable outstanding. Like golf, the lower your score here, the better. The CCC figure for Ingles Markets for the trailing 12 months is 19.6.

For younger, fast-growth companies, the CCC can give you valuable insight into the sustainability of that growth. A company that's taking longer to make cash may need to tap financing to keep its momentum. For older, mature companies, the CCC can tell you how well the company is managed. Firms that begin to lose control of the CCC may be losing their clout with their suppliers (who might be demanding stricter payment terms) and customers (who might be demanding more generous terms). This can sometimes be an important signal of future distress -- one most investors are likely to miss.

In this series, I'm most interested in comparing a company's CCC to its prior performance. Here's where I believe all investors need to become trend-watchers. Sure, there may be legitimate reasons for an increase in the CCC, but all things being equal, I want to see this number stay steady or move downward over time.

Source: S&P Capital IQ. Dollar amounts in millions. FY = fiscal year. TTM = trailing 12 months.

Because of the seasonality in some businesses, the CCC for the TTM period may not be strictly comparable to the fiscal-year periods shown in the chart. Even the steadiest-looking businesses on an annual basis will experience some quarterly fluctuations in the CCC. To get an understanding of the usual ebb and flow at Ingles Markets, consult the quarterly-period chart below.

Source: S&P Capital IQ. Dollar amounts in millions. FQ = fiscal quarter.

On a 12-month basis, the trend at Ingles Markets looks very good. At 19.6 days, it is 4.2 days better than the five-year average of 23.8 days. The biggest contributor to that improvement was DPO, which improved 7.6 days compared to the five-year average. That was partially offset by a 2.9-day increase in DIO.

Considering the numbers on a quarterly basis, the CCC trend at Ingles Markets looks good. At 20.5 days, it is 3.4 days better than the average of the past eight quarters. With both 12-month and quarterly CCC running better than average, Ingles Markets gets high marks in this cash-conversion checkup.

Though the CCC can take a little work to calculate, it's definitely worth watching every quarter. You'll be better informed about potential problems, and you'll improve your odds of finding underappreciated home run stocks.

Can your retirement portfolio provide you with enough income to last? You'll need more than Ingles Markets. Learn about crafting a smarter retirement plan in "The Shocking Can't-Miss Truth About Your Retirement." Click here for instant access to this free report.

  • Add Ingles Markets to My Watchlist.

How Ingles Markets is Bringing Bucks Home More Quickly

It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?"

When judging a company's prospects, how quickly it turns cash outflows into cash inflows can be just as important as how much profit it's booking in the accounting fantasy world we call "earnings." This is one of the first metrics I check when I'm hunting for the market's best stocks. Today, we'll see how it applies to Ingles Markets (Nasdaq: IMKT.A  ) .

Let's break this down
In this series, we measure how swiftly a company turns cash into goods or services and back into cash. We'll use a quick, relatively foolproof tool known as the cash conversion cycle, or CCC for short.

Why does the CCC matter? The less time it takes a firm to convert outgoing cash into incoming cash, the more powerful and flexible its profit engine is. The less money tied up in inventory and accounts receivable, the more available to grow the company, pay investors, or both.

To calculate the cash conversion cycle, add days inventory outstanding to days sales outstanding, then subtract days payable outstanding. Like golf, the lower your score here, the better. The CCC figure for Ingles Markets for the trailing 12 months is 19.6.

For younger, fast-growth companies, the CCC can give you valuable insight into the sustainability of that growth. A company that's taking longer to make cash may need to tap financing to keep its momentum. For older, mature companies, the CCC can tell you how well the company is managed. Firms that begin to lose control of the CCC may be losing their clout with their suppliers (who might be demanding stricter payment terms) and customers (who might be demanding more generous terms). This can sometimes be an important signal of future distress -- one most investors are likely to miss.

In this series, I'm most interested in comparing a company's CCC to its prior performance. Here's where I believe all investors need to become trend-watchers. Sure, there may be legitimate reasons for an increase in the CCC, but all things being equal, I want to see this number stay steady or move downward over time.

Source: S&P Capital IQ. Dollar amounts in millions. FY = fiscal year. TTM = trailing 12 months.

Because of the seasonality in some businesses, the CCC for the TTM period may not be strictly comparable to the fiscal-year periods shown in the chart. Even the steadiest-looking businesses on an annual basis will experience some quarterly fluctuations in the CCC. To get an understanding of the usual ebb and flow at Ingles Markets, consult the quarterly-period chart below.

Source: S&P Capital IQ. Dollar amounts in millions. FQ = fiscal quarter.

On a 12-month basis, the trend at Ingles Markets looks very good. At 19.6 days, it is 4.2 days better than the five-year average of 23.8 days. The biggest contributor to that improvement was DPO, which improved 7.6 days compared to the five-year average. That was partially offset by a 2.9-day increase in DIO.

Considering the numbers on a quarterly basis, the CCC trend at Ingles Markets looks good. At 20.5 days, it is 3.4 days better than the average of the past eight quarters. With both 12-month and quarterly CCC running better than average, Ingles Markets gets high marks in this cash-conversion checkup.

Though the CCC can take a little work to calculate, it's definitely worth watching every quarter. You'll be better informed about potential problems, and you'll improve your odds of finding underappreciated home run stocks.

Can your retirement portfolio provide you with enough income to last? You'll need more than Ingles Markets. Learn about crafting a smarter retirement plan in "The Shocking Can't-Miss Truth About Your Retirement." Click here for instant access to this free report.

  • Add Ingles Markets to My Watchlist.

SEC, FINRA Enforcement Roundup: Allianz, TheStreet Charged

Among recent enforcement actions taken by the SEC were charges against Allianz for violations of the Foreign Corrupt Practices Act that resulted in penalties of more than $12.3 million; against a Connecticut-based advisor for telling clients it was investing in the same collateralized debt obligations it recommended for them; against TheStreet Inc. and three executives for accounting fraud; against a Toronto-based brokerage firm and two executives for allowing layering; and against two investment advisory firms and two portfolio managers in the collapse of a mutual fund.

FINRA, meanwhile, imposed censures and fines for a Toronto firm that inappropriately shared transaction-based commissions with non-FINRA entities, and censures and fines for a Chicago-based firm after it was found to be an introducing broker-dealer established to facilitate U.S. market access for a single large entity and it had failed to design or implement an anti-money-laundering program to track possible violations.

Allianz SE Agrees to Pay Penalty of $12.3 million-plus on FCPA Violations

The SEC charged German-based insurance and asset management company Allianz SE with violating the books and records and internal controls provisions of the FCPA for improper payments to government officials in Indonesia during a seven-year period.

In its investigation, the SEC found 295 insurance contracts on large government projects that were obtained or retained by improper payments of $650,626 by Allianz’s subsidiary in Indonesia to employees of state-owned entities. Allianz made more than $5.3 million in profits as a result of the improper payments.

According to the SEC’s order instituting settled administrative proceedings against Allianz, the misconduct occurred from 2001 to 2008 while the company’s shares and bonds were registered with the SEC and traded on the New York Stock Exchange. Two complaints brought the misconduct to Allianz’s attention. The first complaint, submitted in 2005, reported unsupported payments to agents, and a subsequent audit of accounting records at Allianz’s subsidiary in Indonesia uncovered that managers were using “special purpose accounts” to make illegal payments to government officials in order to secure business in Indonesia. Despite the audit, the payments continued.

According to the SEC’s order, the second complaint was made to Allianz’s external auditor in 2009. Allianz failed to properly account for certain payments in its books and records. The improper payments were disguised in invoices as an “overriding commission” for an agent that was not associated with the government insurance contract. In other instances, the improper payments were structured as an overpayment by the government insurance contract holder, who was later “reimbursed” for the overpayment. Excess funds were then paid to foreign officials who were responsible for procuring the government insurance contracts. Allianz lacked sufficient internal controls to detect and prevent the wrongful payments and improper accounting.

Without admitting or denying the findings, Allianz agreed to cease and desist from further violations and pay disgorgement of $5,315,649, prejudgment interest of $1,765,125, and a penalty of $5,315,649 for a total of $12,396,423.

Connecticut Advisor Charged for ‘Skin in the Game’ Lies to Clients

Connecticut-based Aladdin Capital Management was charged by the SEC with falsely telling clients to whom it recommended two different CDOs that it had “skin in the game” and was investing in the CDOs along with them.

The SEC’s investigation found that Aladdin Capital Management’s co-investment representation was a key feature and selling point for its Multiple Asset Securitized Tranche advisory program involving CDOs and collateralized loan obligations.

For example, Aladdin Capital Management asked in one marketing piece, “Why is an investor better off just investing in Aladdin sponsored CLOs and CDOs?” It then emphasized that the “most powerful response I can give to your question is that Aladdin co-invests alongside MAST investors in every program. Putting meaningful ‘skin in the game’ as we do means our financial interests are aligned with those of our MAST investors.”

Aladdin Capital Management in fact made no such investments in either CDO, and its affiliated broker-dealer Aladdin Capital collected placement fees from the CDO underwriters.

According to the SEC’s order against one of the firms’ former executives, Joseph Schlim, he was significantly involved in the MAST program on a day-to-day basis. He made sales calls to potential clients and negotiated with CDO and CLO underwriters about the amount of equity in those securities that Aladdin Capital could place with customers or purchase for itself. Schlim also negotiated the placement fees to be received by Aladdin Capital for securing MAST investments in equity tranches of each CDO or CLO.

The SEC found that Schlim knew that Aladdin used the co-investment representation as a significant marketing feature in its pitches to clients, but he failed to take any action to ensure that such representations were accurate when they were made. As the CFO of Aladdin, Schlim was responsible for reserving funds for Aladdin to co-invest alongside its MAST clients, yet he failed to ensure that funds were reserved or allocated for any co-investments alongside clients in either CDO.

Aladdin Capital Management and Schlim agreed to cease-and-desist orders without admitting or denying the SEC’s allegations. The Aladdin entities agreed to jointly pay $900,000 in disgorgement, $268,831 in prejudgment interest, and a $450,000 penalty. Schlim agreed to pay a $50,000 penalty to settle charges against him for his role in the misrepresentations.

TheStreet Inc. Charged by SEC with Accounting Fraud

The SEC charged digital financial media company TheStreet Inc. and three executives for their roles in an accounting fraud that artificially inflated company revenues and misstated operating income to investors.

The SEC alleges that TheStreet Inc., which operates the website TheStreet.com, filed false financial reports throughout 2008 by reporting revenue from fraudulent transactions at a subsidiary it had acquired the previous year.

The SEC says the co-presidents of the subsidiary, Gregg Alwine and David Barnett, entered into sham transactions with friendly counterparties that had little or no economic substance. They also fabricated and backdated contracts and other documents to facilitate the fraudulent accounting. Barnett is additionally charged with misleading TheStreet’s auditor to believe that the subsidiary had performed services to earn revenue on a specific transaction when in fact it did not perform the services. The SEC also alleges that TheStreet’s former chief financial officer, Eric Ashman, caused the company to report revenue before it had been earned.

According to the SEC’s complaints filed in federal court in Manhattan, the subsidiary acquired by TheStreet specializes in online promotions such as sweepstakes. After the acquisition, TheStreet failed to implement a system of internal controls at the subsidiary, which enabled the accounting fraud.

The SEC alleges that through the actions of Ashman, Alwine, and Barnett, TheStreet improperly recognized revenue based on sham transactions. It also is alleged to have used the percentage-of-completion method of revenue recognition without meeting fundamental prerequisites to do so, including reliably estimating and documenting progress toward the completion of relevant contracts. In addition, it prematurely recognized revenue when the subsidiary had not performed actual work and therefore had not really earned the revenue.

According to the SEC’s complaint, when the subsidiary’s financial results were consolidated with TheStreet’s financial results for financial reporting purposes, the improper revenue on the subsidiary’s books resulted in material misstatements in the company’s quarterly and annual reports for fiscal year 2008. On Feb. 8, 2010, TheStreet restated its 2008 Form 10-K and disclosed a number of improprieties related to revenue recognition at its subsidiary, including transactions that lacked economic substance, internal control deficiencies, and improper accounting for certain contracts.

Ashman agreed to pay a $125,000 penalty and reimburse TheStreet $34,240.40 under the clawback provision of the Sarbanes-Oxley Act, and he will be barred from acting as a director or officer of a public company for three years. Barnett and Alwine agreed to pay penalties of $130,000 and $120,000, respectively, and to be barred from serving as officers or directors of a public company for 10 years. Without admitting or denying the allegations, the three executives and TheStreet agreed to be permanently enjoined from future violations of the federal securities laws.

SEC Charges Toronto Firm, Execs With Allowing Layering

A Toronto-based brokerage firm, Biremis, saw its license revoked and its two co-founders, Peter Beck and Charles Kim, permanently banned from the U.S. securities industry; all were charged with allowing layering.

In layering, a trader places orders with no intention of having them executed but rather to trick others into buying or selling a stock at an artificial price driven by the orders, which the trader later cancels. The SEC’s investigation found that Biremis–whose worldwide day trading business enabled up to 5,000 traders on as many 200 trading floors in 30 countries to gain access to U.S. markets–failed to address repeated instances of layering by many of the overseas day traders using its system. Beck and Kim ignored repeated red flags indicating that overseas traders were engaging in layering manipulations. Biremis served as the broker-dealer for an affiliated Canadian day trading firm, Swift Trade Inc.

The SEC’s order found that many of the Biremis-affiliated overseas day traders engaged in repeated instances of layering from January 2007 to mid-2010. Beck and Kim learned from numerous sources, including three U.S. broker-dealers and a Biremis employee, that layering was occurring, yet they failed to take any steps to prevent it. For example, in spring 2008, representatives of one U.S. broker-dealer warned Beck and Kim that certain overseas traders were “gaming” U.S. stocks by altering those stocks’ bid and offer prices in order to buy or sell the stock at the altered price. Beck and Kim failed to act on this information.

According to the SEC’s order, Biremis also failed to retain virtually all of its instant messages related to its broker-dealer business, and failed to file any suspicious activity reports related to the manipulative trading.

In addition to the license revocation and bans on Beck and Kim, the two executives agreed to pay penalties of $250,000 each. Biremis, Beck, and Kim neither admitted nor denied the findings contained in the SEC’s order.

Advisory Firms, Investment Managers Charged by SEC in Fund Collapse

Claymore Advisors and Fiduciary Asset Management, as well as two investment managers, were charged by the SEC in the collapse of a Midwest-based closed-end mutual fund.

According to the SEC’s investigation, the Fiduciary/Claymore Dynamic Equity Fund attempted two strategies to enhance returns: writing out-of-the money put options and shorting variance swaps. This exposed HCE to additional undisclosed risks and caused the fund to lose more than $45 million–approximately 45% of its net assets–in September and October 2008. The fund liquidated in 2009.

Fund advisor and administrator Claymore Advisors, located in Lisle, Ill., and the subadvisor responsible for managing HCE’s portfolio, St. Louis-based FAMCO, as well as the portfolio managers responsible for managing the fund, were charged for their roles in the failure to adequately inform investors about the fund’s risky derivative strategies that contributed to its collapse during the financial crisis.

According to the SEC’s orders instituting settled and unsettled administrative proceedings, FAMCO managed HCE in a manner that was inconsistent with the fund’s registration statement. Through the portfolio managers, FAMCO made misleading statements about HCE’s performance, omitting discussion of contributions from the put-writing and variance swap strategies. FAMCO also made misleading statements about HCE’s exposure to downside risk. Investors in HCE lost $45,396,878 as a result of this riskier trading, and the fund lost $70 million altogether (72.4% of its net asset value) during this period of general market decline.

Without admitting or denying the charges, Claymore has established a distribution plan to fully reimburse shareholders for up to $45,396,878 in losses from these derivative transactions. Also without admitting or denying the charges, FAMCO has agreed to pay disgorgement of $644,951, prejudgment interest of $134,978, and a penalty of $1.3 million.

The SEC’s case continues against former FAMCO employees Mohammed Riad of Clayton, Mo., and Kevin Timothy Swanson of St. Louis, the co-portfolio managers who allegedly made misleading statements in HCE’s periodic reports about the two strategies’ contribution to HCE’s performance and about HCE’s exposure to downside risk.

Toronto Firm, Principal Fined, Censured by FINRA on Shared Commissions

Toronto-based Mercator Associates and Fabrizio David Lentini were fined and censured by FINRA over findings that that the firm, acting through Lentini, its head trader, improperly shared transaction-based commissions totaling approximately $4,277,740 with entities that were not FINRA member firms.

Without admitting or denying the allegations, the firm and Lentini consented to the sanctions, which included a fine of $150,000 for the firm and $75,000 for Lentini, and to the entry of findings that the firm, acting through Lentini, sent a series of wire transfers to the bank accounts of non-FINRA entities. The wire transfers were initiated when Lentini received a Letter of Authorization with wire instructions and amounts from the firm’s main customer. Lentini would then take steps to ensure that the requested funds were wired from the firm’s bank account according to the instructions reflected on the LOAs.

The wired funds were generated from trading in some or all of the firm accounts in the names of the non-FINRA entities. Lentini was the firm registered representative assigned to each of those accounts.

The findings also stated that the firm, acting through Lentini, charged excessive commissions that ranged from 5.02% to 31.25% on trades placed in accounts. Lentini was the firm registered representative assigned to those accounts and the firm trader responsible for the execution of the subject transactions. Each of the subject trades was part of the commission-sharing arrangement.

FINRA also found that the firm failed to establish and maintain a supervisory system and establish, maintain and enforce WSPs reasonably designed to achieve compliance with applicable securities laws and regulations; in fact, its supervisory system and WSPs failed entirely to address the commission-sharing arrangement and provide guidance or structure regarding the supervision of securities pricing and commissions.

Numerous other violations, including failure to implement portions of the firm’s AML Compliance Program, failure to obtain the identifying information its Customer Identification Program required about some of the customers that opened accounts with the firm, and to verify that information through documentary or nondocumentary methods, failure to maintain transmittal orders for wire transfers in excess of $3,000, including the name, address and account number of the recipient, and the identity of the recipient’s financial institution and failure to provide any AML training to its personnel for two years, were also found.

Title Securities Fined, Censured on AML Failures, More

Title Securities Inc. of Chicago was censured and fined $150,000 by FINRA on findings that the firm, an introducing broker-dealer established to facilitate direct market access to U.S. markets to a single particularly large customer, failed to implement AML policies, procedures and internal controls that adequately supervised the customer’s transactions.

The firm’s large customer, according to the findings, is a corporation in Cyprus that utilizes the services of an unregistered third-party trading organization to trade its capital. The customer account does a large volume of high frequency trading through the firm, averaging trades of as many as 3 billion shares per month.

The findings stated that the firm failed to develop and implement an AML program tailored to its business model, so its AML policies, procedures and internal controls could not reasonably be expected to monitor, detect and cause the reporting of suspicious or manipulative trading activity. The AML procedures also did not include red flags for the firm to monitor for in connection with suspicious trading activity.

The firm also did not make reasonable efforts to ensure that each trader was only issued one trader ID or to terminate inactive IDs, so traders were able to use multiple trader IDs to bypass the wash sale filters, to circumvent surveillance monitoring, to have access to higher trading limits through the use of multiple IDs and to potentially continue trading under a different trader ID.

FINRA also found that the firm received numerous inquiries from its clearing firm, as well as from FINRA, BATS, NYSE ARCA and NASDAQ concerning wash trading, odd lots and layering in the customer account. Despite being placed on repeated notice of potentially manipulative trading in the customer account, the firm failed to establish meaningful controls.

Without admitting or denying the findings, the firm consented to the fine, which will be paid jointly to FINRA, The NASDAQ Stock Market, BATS Exchange Inc. and NYSE ARCA Inc., and to the entry of the findings.

Cisco Dow’s Best Performer In November, Raymond James Sees 30%+ Upside

Shares of Cisco (CSCO) were inching their way ahead this morning, on a bullish note from Raymond James ahead of the company�s upcoming analyst meeting, and is on track to be the month�s top performing Dow stock.

On this last trading day of November, Cisco is up nearly 11% for the month, well outpacing its second-closest rival, Bank of America (BAC).

Other big tech names weren�t so lucky: Intel (INTC) turned in the Dow�s worst November performance, down almost 10%; Hewlett-Packard (HPQ) was next on the list, down nearly 7%.

Raymond James�s Simon Leopold today reiterated his Outperform rating and $25 price target on Cisco, ahead of next� Friday�s analyst day. �We expect Cisco outlines its strategic vision to become a broader IT supplier with a greater software bias, which aids margin. We doubt the event represents a material catalyst, but should clarify Cisco’s vision. As a tech bellwether, Cisco’s commentary sets the table for the 2013 macro environment. We expect Cisco maintains its 5-7% long term growth target while offering cautious commentary on the near term.�

Analysts were also largely positive about Cisco�s purchase of Cariden, announced yesterday.

Financials, Bullish Sentiment, And The 2012 Winter Resolution

The least movement is of importance to all nature. The entire ocean is affected by a pebble. -- Blaise Pascal

Even though we're only in the third trading day of the year for 2012, there has already been a tremendous amount of change happening internally within the markets. On Tuesday, Utilities (XLU) fell apart while the S&P 500 rallied. Further weakness continued in defensive sectors such as Consumer Staples (XLP), and Healthcare (XLV), even on quiet days for overall market movement. Treasury Inflation Protected Securities (TIP) are performing nicely, while long bond yields (TLT) have been slowly creeping up.

It is as if with the blink of an eye inflation expectations are returning. Perhaps the best way of thinking about this is how a ketchup bottle works. If central banks around the world have been shaking the ketchup bottle with no result, perhaps now is the time when the ketchup (inflation expectations) spills forth. Could it be that the Winter Resolution trend I have been talking about will be a bull market up move, despite Europe?

Market internals seem to be suddenly betting on rising inflation expectations, and should this continue, I think it's game on for the bulls. What would really cement this is if the financials (XLF) sector sustainably outperforms. And yes – it appears that this may indeed be in the early stages of happening -- finally. Take a look below at the price ratio of the Financials Select Sector SPDR ETF relative to the S&P 500 (IVV). As a reminder, a rising price ratio means the numerator/XLF is outperforming (up more/down less) the denominator/IVV.

We all know that financials have significantly underperformed markets since September of 2009, when the above price ratio peaked. The ratio got hammered all of 2011. Looking at the far right of the chart, it does appear to be the case that bets are being placed on banks in what could be the start of an early period of outperformance in the sector. I am not making a fundamental case for banks here. Everyone knows that banks face collateral problems. Everyone knows about Europe. The question is if markets have over or under-reacted to that. If bad news is overly priced in, then financials could lead the markets higher. The Winter Resolution may bring the bull back for real this time.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Thursday, December 20, 2012

Analysts Look Back: Our Best and Worst Stocks of 2012

Over the past year, we three Foolish analysts -- Travis Hoium, Alex Planes, and Sean Williams -- have come together to decide whether certain stocks were worth your money or whether you'd be better off staying away. We've been debating the merits of individual stocks all year, and after 21 up-or-down picks, we're beating the S&P 500 by nearly 200 points.

A new year is fast approaching, so we thought we'd take a look back at our selections to give you an understanding of how we reached our decisions, what our thought processes might have been, and how we've learned from our mistakes to make sure that 2013 brings even better results to our TMFYoungGuns CAPS portfolio. Today, we'll be taking a look at our favorite calls, as well as the calls we've been burned on. Coming up later this week, we'll also take a look at the hardest calls we've had to make, our biggest regrets, and the picks we've made where we wished our two fellow analysts had seen it our way.

Favorite call
Alex: Is there going to be any disagreement here? We all thought Green Mountain Coffee Roasters (NASDAQ: GMCR  ) was undervalued in July, and it's been by far our best-performing stock since that call. I've been repeatedly surprised at the strength of its rebound, but I'm not going to look this gift horse in the mouth as long as it keeps running so well. I'm proud of the analysis I put Green Mountain through in that debate, and it's vindicated my optimism well beyond my early expectations.

Travis: My two favorite picks are actually losers for us so far, but they were unanimous selections that went against the grain. First is our underperform call on Amazon.com (NASDAQ: AMZN  ) which is one of The Motley Fool's newsletter's best picks. We said in March that the stock would underperform the market, and since then sales growth has slowed and profits have tumbled. This hasn't led to a falling stock price, but give it time.

Second is our outperform call on SunPower (NASDAQ: SPWR  ) , which we knew was a risky pick but we all thought would outperform over the very long term. It hasn't made us anything yet, but margins are improving and competitors in China are getting weaker by the day. In another year this may be our top performer.

Sean: I, too, was tempted to make Green Mountain my favorite pick thus far, but instead I've chosen Bank of America (NYSE: BAC  ) which has returned 30 points over the S&P 500 in just three months. I've owned Bank of America in my personal portfolio for more than a year, and it's vindicating to see a bank so incredibly cheap relative to book value turning things around and improving its liquidity. My only regret is not throwing B of A on the table in front of Alex and Travis sooner!

Worst call
Alex: We may have dodged a bullet by avoiding Chipotle Mexican Grill (NYSE: CMG  ) in June, but our indecision cost us almost 40 points on an underperform call. Sean was the only one who saw an overvalued company that was bound to run into trouble, but I don't think he knew just how quickly trouble would come. It was clear to me then that Chipotle was a bit richly valued, and had I paid closer attention to the trend rather than the average, I would have joined Sean in predicting underperformance.

Travis: We've all been very wrong on the near-term fortunes of Intel (NASDAQ: INTC  ) . We underestimated the decline of the PC market and how little the market would appreciate what we perceived as value. Right now, this is our worst pick and there doesn't appear to be any momentum building in the near future.

Sean: I feel we all allowed emotion and near-term negativity to cloud our better judgment when we chose Carnival (NYSE: CCL  ) to underperform in May. The cruise line operator had dealt with two devastating disasters just months before and we all assumed that it'd be a year or two before things were completely sorted out. However, consumer spending on cruises dipped for only a few weeks and Carnival's results have improved steadily since our selection.

Foolish final thoughts
It certainly has been an interesting year to debate stocks. As you can see, even when we arrive at similar decisions, we can always find a way to approach those decisions with a unique perspective. The three of us look forward to debating many more stocks next year, and we hope you'll follow along. We're always interested in finding out what our readers think, so feel free to leave us a comment below. If you'd like to follow our selections, you can watch our TMFYoungGuns CAPS portfolio.

Sean's best call has trounced the market in 2012, but will B of A continue to be one of our best calls in 2013? The banking industry can be confusing if you're not well versed in its intricacies, which is why The Motley Fool has created an�exclusive premium research service�for interested investors. You'll find a wealth of great information explained simply, whether you're a long-term investor or are just looking to jump in today. Got questions on Bank of America? Get the answers you need in our research service.�Click here to subscribe now.

Should I Buy British American Tobacco?

LONDON -- It's time to go shopping for shares again, but where to start? There are loads of great stocks to choose from, and I've got my wallet out. So here's the question I'm asking right now. Should I buy�British American Tobacco� (LSE: BATS  ) (NYSEMKT: BTI  ) ?

Still smokin'
Tobacco companies' products might kill you, but their stocks can be a lifesaver in a recession. Smokers still need their fix in hard times, and defensive investors can get high on the fumes. British American Tobacco hasn't made anybody rich this year. Its share price has risen a modest 3% since January to 31.76 pounds, but once you throw in its 4% yield, it has easily beaten cash. And that's what defensive stocks are supposed to do. I don't smoke, but could the world's second-biggest tobacco company light up my portfolio?

Death and taxes
Defensive doesn't mean failsafe. British American Tobacco is actually down 11% since early August, amid concerns that cigarettes are, ahem, a dying product. High taxes and health awareness have hit sales in the developed world, and I would expect that trend to continue, and eventually spread to emerging smokers. Chief executive Nicandro Durante is already preparing for this. He founded BAT's special Nicoventures unit, which is developing a range of non-inflammable products, such as smokeless cigarettes and nicotine inhalers, chewing tobacco and snuff. Durante may be wise to the threat, but I question whether these baccy alternatives will give smokers the kick they need, except maybe to quit.

Take BAT!
There are other threats. Excise tax hikes may not stop people from smoking, but they do drive smokers toward cheaper brands or the black market, hitting BAT's volumes. Governments are likely to keep up the squeeze on tobacco companies, pushing for stomach-churning pictures on the packaging. With Western governments desperate to raise tax revenues, the evil weed will remain an easy target. Plus there is the growing danger of class action litigation from smokers who claim tobacco companies have underplayed the health risks.

Smoking thrills
Yet the world is still full of smokers. Sales of BAT's four big global brands -- Dunhill, Kent, Lucky Strike and Pall Mall -- grew 3% in the nine months to September. Group revenue grew 4%, as the company got its pricing strategy right. But overall, volumes fell 1.8%, in line with a general industry decline. BAT is the most geographically diversified major tobacco company, and although China remains closed to Western tobacco, it is seeking new opportunities in Asia, Africa, Eastern Europe, and the Middle East. But what investors really crave in a tobacco stock is the dividend, and BAT's 4% yield is healthier than any of its products. Despite recent falls, I wouldn't call BAT cheap, trading at 15.4 times earnings. But it has resumed its share buyback program, which should support the share price. BAT looks a buy to me.

Bulletproof
If tobacco stocks aren't to your taste, you might lick your lips when you discover the�one U.K. share that Warren Buffett loves. This special in-depth report completely explains exactly why�Warren Buffett bought this share. Better still, it is completely free and without any obligation. Availability is strictly limited, so if you want to know the name of this company, please�download it now.

link

Getco Merging With Knight Capital for $2 Billion

Electronic trading firm Getco Holdings announced in a press release Wednesday that it will acquire Knight Capital Group (NYSE: KCG  ) for $1.4 billion. The two companies will be combined under a new holding company to be publicly traded at the completion of the merger.

The deal offers Knight shareholders $3.75 per share, a premium of more than 13% over its Tuesday closing price. It's a victory for Knight after its software trading glitch in August led to a trading loss of more than $400 million and nearly resulted in bankruptcy for the company. Getco was one of a group of investors that bailed out Knight during the fiasco.

Knight Chairman and CEO Thomas M. Joyce summarized ��the rationale for the deal in Getco's release, saying, "The transaction provides near-term certainty in the form of cash, while also allowing shareholders to benefit from participation in the future success of the firm."

Shares of Knight surged on the day, picking up 6% in afternoon trading to eclipse the $3.50 per-share mark.

Path to First Class

Reaching elite status levels can seem like an unattainable goal for "regular" customers who don't live on the road. ButScott McCartney joins The News Hub. with the tricks and cheap ways to become airline elite. Photo: Reuters.

The top ranking in frequent-flier programs has long been considered the privilege of elite road warriors�people who buy expensive tickets, spend their working lives traveling and always get upgraded and pampered.

But with a relatively modest investment of $4,000 to $7,000 a year and some creativity and adventurousness, an occasional traveler can buy top-tier status and turn it into tens of thousands of dollars worth of business-class upgrades on international trips, plus bonus miles, airport-lounge access, domestic first-class upgrades and even perks like Tiffany & Co. gift cards.

Status pays�and buying status can quickly pay for itself. Besides cushy perks and priority, travelers in the highest tier of frequent-flier programs get several free international upgrades a year. With each one, a $1,200 round-trip economy ticket to Europe or Asia can be turned into a $7,000 business-class bed.

"I believe elite status is a huge value. It just makes your life easier," said Joe Nevin, a former Silicon Valley executive who takes five or six far-flung trips a year to get "Premier 1K" status on United Airlines. For his investment of $5,000 to $6,000, plus hours of flying to various destinations, he and his wife travel on free tickets and free upgrades all year long. "It boggles my mind that some people just don't make it a priority," he said.

US Airways Group sells "Chairman Preferred" status in its Dividend Miles program for $3,999 with no flying. Lower levels of status are cheaper, and the "Buy up to Preferred" program can be used to top off accounts to hit annual status qualification targets.

"It's been a very successful program," said Fern Fernandez, managing director of customer loyalty and marketing programs. Some customers use it after job changes to keep the same status they are accustomed to, even though they may not be flying as much on US Airways.

View Interactive

Randall Stempler (4); Oxford Scientific/Getty Images (Sri Lanka); Alamy (3)

Investment an occasional traveler can make and turn into tens of thousands of dollars worth of seat upgrades and other perks

Other airlines don't sell status outright, except for occasional offers to let people requalify for their status level by paying $500 to $1,000 or so when they come up short in mileage at the end of a year. But serious travel junkies have mastered the concept of the "mileage run" or "status run"�taking long, cheap trips simply to accumulate miles and achieve status. With 1K status, Mr. Nevin gets upgraded virtually every time, he said. He gets a 100% bonus in miles that can be used on free trips. He searches airline website calendars to find the cheapest days to travel, plus sophisticated Web tools such as ExpertFlyer and the free ITA Software that track specific airline inventory. He'll price out flights to Manila, Singapore, Hong Kong, Bangkok, Dubai and other destinations. He keeps a chart by his computer with round-trip mileage for those and other destinations.

Mr. Nevin, who now runs a mogul- and powder-skiing school in Aspen, Colo., says he gets 17,000 to 21,000 "elite-qualifying miles," or EQMs, on each of his status runs. EQMs are different from everyday frequent-flier miles. They are actual flying miles: Most miles earned through credit cards, restaurants, hotels and other merchants, plus bonus miles, typically don't count toward elite qualification. (Some high-end credit cards from the likes of Chase, American Express and Citibank do offer a limited number of EQMs a year.) To get to 100,000 EQMs (which are known as PQMs at United, for Premier Qualifying Miles), he spends $5,000 to $6,000 a year.

"I can knock off 100,000 miles in five trips," he said. "Being a married guy, I try to balance my wife's tolerance for this stuff."

Early in 2013, he'll be off to Hong Kong. He paid $1,030 for the ticket from Aspen and will collect about 18,500 miles. He has another trip booked to Tokyo on United's Boeing 787 Dreamliner that he bought on a $989 promotional fare when United first announced the service. The trip will deliver 11,560 elite-qualifying miles.

"The whole thing is being opportunistic," Mr. Nevin said. "You've got to beat the system."

Enlarge Image

Close

New York lawyer Randall Stempler likes to ring in the New Year as far away from home as possible�preferably in a warm place. Buenos Aires is a favorite. Last year he was in Sydney. This year he'll be in Singapore, flying home Jan. 1 through Tokyo and Houston for extra miles. The trip will give him 11,371 elite-qualifying miles to jump-start his 2013 1K requalification. Along with the EQMs, he'll pocket 44,000 total frequent-flier miles�almost enough for a domestic first-class ticket on United.

"My holiday card every year is me in some city around the world," said Mr. Stempler. When he got married last year, he jokingly asked his wife if she was marrying him for his 1K status. He tries to work in some fun with his status runs.

Early next year he'll fly from New York to Honolulu for a three-day weekend�for sun and miles with a full day in Hawaii. To pass the time on planes, he brings a shopping bag full of newspapers and magazines. Since he wants to go to places at certain times, he pays more and spends about $8,000 to $10,000 a year maintaining 1K status.

Airlines typically give standard perks, such as early boarding, priority lines at ticket counters and security checkpoints and extra coach-seat legroom, to all elite-level frequent fliers. But as you move up the tiers, the benefits increase dramatically.

Members at the highest published level typically get domestic first-class upgrades confirmed four to seven days before departure. Members at the lowest elite level typically get upgrades no more than 24 hours before departure�if there are any seats left.

On most airlines, the highest level of elite members get 100% mileage bonuses or more for their trips, making it easier to claim free trips, and guaranteed access to any flight. If it's sold out, top-tier fliers can still buy a seat and the airline likely will bump another customer, either enticing them voluntarily with vouchers toward future travel or bumping them involuntarily and paying compensation.

A few airlines give their top-tier customers better availability of mileage-award seats. Some offer special bonuses. Delta offers a choice of gifts to Diamond members, including a $200 Tiffany gift card.

{if djIsFlashPossible}

The version of Adobe Flash Player required to view this interactive has not been found. To enjoy our complete interactive experience, please download a free copy of the latest version of Adobe Flash Player here

{else}

This content can not be displayed because your browser does not support the Adobe Flash player required to view it.

{/if}

United reimburses its 1K customers for the $100 enrollment fee for the federal Global Entry program, which lets travelers bypass immigration lines when re-entering the country, and gets you enrolled in the Transportation Security Administration's "Pre-Check" expedited screening program.

Both United and American have even higher unpublished levels, available by invitation only. United's "Global Services" level and American's "Concierge Key" are both based not just on miles traveled but, on the revenue generated by each traveler.

By selling status with its "Buy up to Preferred" program, US Airways collects the money mileage runners are willing to pay, and gets to sell the seats they would have occupied to other customers.

This is the busy season for selling status, Mr. Fernandez said. Mileage runners typically squeeze in trips before Dec. 31 to requalify, and come January, travelers who didn't hit status targets by flying are ready to buy the status they want.

Airlines say they monitor programs closely to see whether people gaming the system�some of whom refer to themselves as "travel hackers"�are taking too many seats from road warriors who spend a lot more on tickets.

Still, even selling status, "we haven't seen an increase in activity that would be a concern," Mr. Fernandez said.

Friday’s ETF Chart To Watch: SPDR S&P Retail ETF (XRT)

Stock markets have endured an up-down week thanks to looming Euro zone debt woes plaguing investors’ confidence. Volatility levels remain elevated as the threat of Greece exiting the euro appears to have intensified. On the home front, economic data releases have been largely positive; new home sales data beat expectations, along with stronger-than-expected durable goods orders in April. Major equity indexes appear to be stabilizing, although lingering Euro zone drama may very easily steal the headlines next week�[see ETF Technical Trading FAQ].�

Investors will turn their attention to the latest University of Michigan Consumer Sentiment report later today to gain more insights into the health of the domestic consumer. As such, the State Street SPDR S&P Retail ETF (XRT) is on our radar screen for the day as it may see an increase in trading volumes following this release. Analysts are largely expecting for the sentiment reading to come in unchanged from last month at 77.8 [see also 3 ETF Trading Tips You Are Missing].�

Chart Analysis

XRT has endured a healthy correction over the past few weeks since topping out at $63.04 a share on 3/27/2012. This ETF appears to be establishing support around current levels, although caution should be exercised as it may retest support around its 200-day moving average (yellow line) or $55 a share. From a longer-term perspective, despite its recent correction, XRT appears poised to continue its trek higher, moving along the same upward sloping support line (blue line) since hitting a low at $43.50 a share on 8/19/2011.

Click To Enlarge

One potentially bearish piece of evidence however is the fact that trading volumes have decreased over the past five days, while the price has risen; this divergence between price action and volume may signal a potential reversal, although the trend is still up until support at $57 a share is broken [see also 101 ETF Lessons Every Financial Advisor Should Learn].�

Outlook

If consumer sentiment paints an optimistic outlook, the domestic retail sector could have the wind at its back. Likewise, XRT may climb back over $60 a share, although caution should be exercised as it nears $62 a share, seeing as how this is a major�resistance�level. On the other hand, a�disappointing�report may very well spell trouble for XRT on the day. In terms of downside, this ETF has support at the $57 level.�As always, investors of all experience levels are advised to use stop-loss orders and practice disciplined profit taking techniques.

Follow me on Twitter�@SBojinov

[For more ETF analysis, make sure to sign up for our�free ETF newsletter�or try a�free seven day trial to ETFdb Pro]

Wednesday, December 19, 2012

Pitney Bowes Names Former IBM Executive Its New CEO

After 27 years with IBM (NYSE: IBM  ) , Marc B. Lautenbach is taking� over the CEO role at Pitney Bowes (NYSE: PBI  ) effective immediately, according to an announcement today from the latter company. Lautenbach replaces former Pitney Bowes Chairman, CEO, and President Murray Martin, who will temporarily remain in an advisor capacity to assist in the transition. Martin has been with the company 26 years.

Pitney Bowes also announced that Michael Roth has been named non-executive chairman of the board, effective immediately.

Lautenbach's tenure with IBM included leadership of its Small and Medium Business (SMB) unit, in addition to several other leadership roles. Most recently, Lautenbach, 51, led the IBM North America Global Business Services division. Lautenbach has also been appointed to a position on Pitney Bowes' board.

According to Roth, "Marc [Lautenbach] is ideally suited to lead Pitney Bowes, and as the non-Executive Chairman, I look forward to working closely with Marc and the senior management team to execute on our strategy to be a leading provider of customer communications solutions."


link

Best Stocks To Invest In 2012-2-13-3

 

 

Exelixis to receive $12M upfront payment and be eligible for potential development, regulatory and commercial milestones, plus royalties

SOUTH SAN FRANCISCO, Calif — (CRWENEWSWIRE) — Exelixis, Inc. (NASDAQ:EXEL) today announced that it has granted to Merck, known as MSD outside of the United States and Canada, an exclusive worldwide license to its PI3K-delta research and development program, including XL499, the company�s most advanced preclinical PI3K-delta inhibitor and other related compounds. Under the agreement, Merck will have a worldwide exclusive license and have sole responsibility to research, develop, and commercialize compounds originating from the program.

Merck will make an upfront payment of $12 million to Exelixis and Exelixis will be eligible for potential development and regulatory milestone payments for multiple indications of up to $239 million. Exelixis will also be eligible for potential combined sales performance milestones and royalties on net-sales of products emerging from the agreement. Milestones and royalties are payable on compounds emerging from Exelixis� PI3K-delta program or from certain compounds that arise from Merck�s internal discovery efforts targeting PI3K-delta during a certain period.

�PI3K-delta is an interesting target with potential utility in a number of therapeutic areas, including inflammation and oncology,� said Michael M. Morrissey, Ph.D., president and chief executive officer of Exelixis. �Our PI3K-delta program builds on our prior interest in the PI3K family, which led to the advancement of pan-PI3K inhibitors into clinical development for cancer. Merck�s global presence and significant resources make it the ideal organization to carry the PI3K-delta program forward. At the same time, this agreement provides Exelixis with resources for the continued development and potential commercialization of our lead compound, cabozantinib, which is in late-stage development for medullary thyroid and prostate cancers.�

�Exelixis has established a strong reputation for innovation in the development of targeted kinase inhibitors,� said Don Nicholson, Ph.D., Vice President and Head of Worldwide Discovery, Respiratory and Immunology Franchise, Merck Research Laboratories. �Collaborations like this are an important part of our strategy as we seek new ways to address unmet needs in inflammatory disease and oncology.�

PI3K-delta is a member of the Class 1 family of phosphoinositide-3 kinases and is predominantly expressed in cells of the immune system. Activation of PI3K-delta occurs in response to a variety of immune cell stimuli, and inappropriate PI3K-delta activation is thought to contribute to multiple inflammatory and allergic disorders, including rheumatoid arthritis and allergic asthma. Selectively targeting PI3K-delta has also shown potential in the treatment of certain lymphomas.

About Exelixis

Exelixis, Inc. is a biotechnology company committed to developing small molecule therapeutics for the treatment of cancer. Exelixis is focusing its proprietary resources and development efforts exclusively on cabozantinib, its most advanced solely-owned product candidate, in order to maximize the therapeutic and commercial potential of this compound. Exelixis believes cabozantinib has the potential to be a high-quality, differentiated pharmaceutical product that can make a meaningful difference in the lives of patients. Exelixis has also established a portfolio of other novel compounds that it believes have the potential to address serious unmet medical needs. For more information, please visit the company’s web site at www.exelixis.com.

Forward-Looking Statements

This press release contains forward-looking statements, including, without limitation, statements related to: the payment to Exelixis of an upfront payment; Exelixis’ potential receipt of development, regulatory and sales milestones, as well as royalties on sales of products; the clinical, therapeutic and commercial potential of the PI3K-delta program; the belief that Merck is the ideal organization to carry the PI3K-delta program forward; the belief that the agreement will provide resources for the continued development and potential commercialization of cabozantinib; and the clinical, therapeutic and commercial potential of cabozantinib. Words such as “will,” �eligible,� �potential,� �emerging,� �arise,� �provides,� �continued,� and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Exelixis’ current plans, assumptions, beliefs and expectations. Forward-looking statements involve risks and uncertainties. Exelixis’ actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation: risks related to Exelixis’ dependence on the activities of Merck under the described agreement, the potential failure of the PI3K-delta program or cabozantinib to demonstrate safety and efficacy in clinical testing; the therapeutic and commercial value of the PI3K-delta program and cabozantinib; Exelixis’ ability to conduct clinical trials of cabozantinib sufficient to achieve a positive completion; the sufficiency of Exelixis’ capital and other resources; uncertain timing and level of expenses associated with the development of cabozantinib; the uncertainty of the FDA approval process; market competition; and changes in economic and business conditions. These and other risk factors are discussed under “Risk Factors” and elsewhere in Exelixis’ quarterly report on Form 10-Q for the quarter ended September 30, 2011 and Exelixis’ other filings with the Securities and Exchange Commission. Exelixis expressly disclaims any duty, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Exelixis’ expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

Source: Exelixis, Inc.

Contact:
Exelixis, Inc.
Charles Butler, 650-837-7277
Vice President, Investor Relations and Corporate Communications
cbutler@exelixis.com

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

51job Shares Jumped: What You Need to Know

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Just as U.S. recruiters were surging, shares of Chinese job-search site 51job (Nasdaq: JOBS  ) closed up 9% after a 12% initial surge in early trading. Volume was lighter than average, suggesting an abundance of buy orders versus few sells.

So what: The buying makes sense. Both Chinese and outside firms are hiring the region. Germany's SAP (NYSE: SAP  ) last week announced plans to invest $2 billion in China, bringing "thousands of jobs" to the Sino superpower between now and 2015.

Now what: SAP isn't alone; 51job booked 49% growth in online recruitment in its most recent quarter. Adjusted earnings grew 55% to $0.59 over the same period -- six cents more than analysts were calling for. Does it matter? Would you buy shares of 51job at current prices? Please weigh in using the comments box below.

Interested in more information about 51job? Add it to your watchlist.

This Just In: Upgrades and Downgrades

At The Motley Fool, we poke plenty of fun at Wall Street analysts and their endless cycle of upgrades, downgrades, and "initiating coverage at neutral." Today, we'll show you whether those bigwigs actually know what they're talking about. To help, we've enlisted Motley Fool CAPS to track the long-term performance of Wall Street's best and worst.

Sun rises in the West
On Monday, an arbitration tribunal in Minnesota told Western Digital (NYSE: WDC  ) to pay $525 million to archrival Seagate Technology (Nasdaq: STX  ) -- compensation for allegedly having poached a former Seagate employee and "misappropriated" confidential information and trade secrets known by this employee. Seems a strange time to decide to recommend buying Western-D ... but that's just what Barclays Capital decided to do.

In quick succession, Western-D has suffered a sales slump from consumers gravitating to flash memory-equipped smartphones, tablets, and ultrabooks, gotten hit by flooding of its factories in Thailand, handed over a huge chunk of market share to Seagate (which wasn't as badly hurt by the flooding) -- and now lost the arbitration award. As Barclays points out, pretty much everything bad that could have happened to Western Digital has happened already. Enough is enough, and if there's any fairness in the Universe at all, the next news out of Western Digital should be good news.

An-ti-ci-pation ...
How long must we wait for this long-delayed good news to arrive? Sadly, Barclays makes no promises of immediate gratification. To the contrary, the analyst says you need to "look past" at least a couple of quarters to find any light at all at the end of this tunnel.

But once you do, what you'll see is that "WD will be able to begin improving production by the June quarter and could systematically begin regaining share" in the second half of 2012. Moreover, Barclays predicts that Western Digital's "pending acquisition of Hitachi GST will be very accretive to earnings -- on the order of $5.00 in earnings power by 2H CY12." So basically, if an investor can hold his or her breath for the next six to nine months, the reward could ultimately be a 50% increase in annual profits.

Is that good enough?
If Barclays is right about this, then Western Digital's current difficulties are giving us a chance to own this stock at the low, low price of about 5 times "normal" earnings. That's not a bad price for a company that most folks on Wall Street expect to grow at 8% per year over the next five years. It's downright cheap when you consider that Western-D generates free cash flow at a rate 18% above what it reports as GAAP "net income."

Flash-memory specialists like STEC (Nasdaq: STEC  ) and SanDisk (Nasdaq: SNDK  ) can't say the same. OCZ (Nasdaq: OCZ  ) and Micron (Nasdaq: MU  ) are actually burning cash. And speaking of cash, did I mention that more than half of Western Digital's market cap is backed up by cold, hard cash in the bank?

Foolish takeaway
Listen, Fools -- I know it's hard to be a Western Digital shareholder these days. The stock's underperformed the Dow Jones Industrial Average (INDEX: ^DJI  ) by 26 percentage points over the past year, and that hurts. To be honest, I don't even know for certain when this trend will turn around. Barclays could be right that the turnaround is coming in six to nine months ... or it could be wrong. It could take longer.

What I do know is that when I run the numbers on Western Digital today, I see a stock whose enterprise value is only 3 times the amount of free cash flow it generated over the past year -- a stock that even pessimistic analysts agree will probably keep on growing at 8% or so annually over the next five years. That sounds cheap to me.

Does it sound cheap to you? Tell us on Motley Fool CAPS.

Looking for more bargains to invest in? Then you're in luck. It just so happens we've found another one for you: Read all about it in our new -- and free! -- report: "The Motley Fool's Top Stock for 2011."